Backenroth Samuel is Chief Financial Officer of Notable Labs Ltd.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Vascular Biogenics Ltd.
18 Apr 23
3
Vascular Biogenics Ltd.
3 Jan 23
4
NeuBase Therapeutics, Inc.
30 Dec 20
4
NeuBase Therapeutics, Inc.
4 May 20
4
NeuBase Therapeutics, Inc.
16 Jul 19
4
Ohr Pharmaceutical Inc
18 Oct 17
4
Ohr Pharmaceutical Inc
13 Apr 17
4
Ohr Pharmaceutical Inc
21 Jun 16
4
Ohr Pharmaceutical Inc
24 May 16
4
Ohr Pharmaceutical Inc
11 Jan 16
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar 23 | NTBL Notable Labs | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 525,000 | 0.00 | 525,000 |
31 Mar 23 | NTBL Notable Labs | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 525,000 | 0.00 | 175,000 |